oral cancer vaccine V3-P

{
  "id": "MLC-T-ONC-015692",
  "term": "oral cancer vaccine V3-P",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable, therapeutic cancer vaccine composed of the carbohydrate antigen sialyl-Lewis A (carbohydrate antigen 19-9; CA19.9; CA19-9) that is derived from pooled blood of pancreatic cancer patients, with potential immunomodulating activity. Upon oral administration of the oral pancreatic cancer vaccine V3-P, the CA19.9 antigens may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL)-mediated immune response against pancreatic cancer cells expressing the CA19.9 antigen. CA19.9 is overexpressed on a number of different tumor cell types and plays a key role in tumor cell survival and metastasis.",
  "synonyms": [
    "cancer vaccine V3-P",
    "oral tableted therapeutic vaccine V3-P",
    "V3-P cancer vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/oral-cancer-vaccine-v3-p/"
}